UnionTech Closes $30M Funding Round
UnionTech, a Shangai, China-based leader in the 3D printing industry, completed a $30m Pre-IPO funding following the completion of the Series D round in November last year.
UnionTech, a Shangai, China-based leader in the 3D printing industry, completed a $30m Pre-IPO funding following the completion of the Series D round in November last year.
Sender, a NEAR-based eco-wallet, raised US$4.5m in funding.
MetaWeb Ventures, a NYC-based global venture capital firm focused on pre-seed and seed investments in crypto startups, launched its first fund, with total capital commitments of $30m USD.
NetEase Games, the games division of NetEase, Inc. (NASDAQ: NTES, HKEX: 9999), a Chinese internet and online game services provider, acquired Quantic Dream S.A., a Paris, France and Montreal, Canada-based premier independent video game developer.
Neukio Biotherapeutics, a Chinese company committed to developing cell therapy products, raised $50M in Series A-1 funding.
Yoyi Tech, a Beijing, China-based omnichannel intelligent marketing platform service provider, closed a USD20m D+ financing.
DAM Finance, a Shanghai, China-based provider of a protocol for creating purchasing power from cross-chain token portfolios, raised $1.8M in Pre-Seed funding.
Porton Advanced Solutions, a Suzhou, China-based provider of gene and cell therapy (GCT) CDMO platform to help bring new therapies to patients, closed its Series B financing round with over US$80m.
.bit, a US, China, and Singapore-based developer of a cross-chain decentralized identity protocol, raised $13m in Series A funding.
Carbonstop, a Beijing, China-based provider of carbon emissions management software and consulting solutions, raised 100m Yuan ($14.82m) in Series B funding.
Epigenic Therapeutics, a Shanghai, China-based biotechnology company, raised $20M in Series Angel and Pre-A funding.
Sanyou Biopharmaceuticals Co., Ltd., Shangai, China-based provider of a platform for the high-throughput and integrated R&D and value transformation of innovative antibody drugs, closed a Series B+ financing round of tens of millions of RMB.
Sironax, a Beijing, China-based biotechnology company dedicated to the discovery and global development of novel treatments for patients with age-related degenerative diseases, closed a $200m Series B financing.
NTX, a Singapore- and Shangai, China-based global textile technology company, completed nearly 200 million US dollars in a C2 round of financing.
Tuotuo Digital, a Beijing, China-based cross-border fintech and payment service provider, completed a new round financing of tens of millions of CNY.